KRONOS BIO INC. - COM
0.8775
08-October-24 13:04:09
15 minutes delayed
Stocks
-0.1125
-11.36%
Today's range
0.8520 - 0.9800
ISIN
N/A
Source
NASDAQ
-
12 Oct 2022 04:04:45 By Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
22 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
16 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Second-Quarter 2022 Financial Results
04 Aug 2022 16:05:02 By Nasdaq GlobeNewswire
-
10 Jun 2022 03:04:36 By Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
01 Jun 2022 16:05:01 By Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in H.C. Wainwright Global Investment Conference
17 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
12 May 2022 10:23:18 By Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and First-Quarter 2022 Financial Results
04 May 2022 16:05:02 By Nasdaq GlobeNewswire
-
08 Mar 2022 17:08:22 By Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Cowen 42nd Annual Health Care Conference
01 Mar 2022 07:00:02 By Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results
24 Feb 2022 16:05:00 By Nasdaq GlobeNewswire
-
Kronos Bio Announces Appointment of Elizabeth Olek as Senior Vice President of Clinical Development
01 Feb 2022 16:05:00 By Nasdaq GlobeNewswire
-
06 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
Kronos Bio Announces Positive Data from Ongoing Phase 1/2 Trial of Oral CDK9 Inhibitor KB-0742
29 Nov 2021 07:00:00 By Nasdaq GlobeNewswire
-
Kronos Bio Announces Participation in Upcoming Investor Conferences
24 Nov 2021 07:00:00 By Nasdaq GlobeNewswire
-
Kronos Bio Appoints Roshawn Blunt to Board of Directors
11 Nov 2021 16:05:00 By Nasdaq GlobeNewswire
-
Kronos Bio Reports Recent Business Progress and Third-Quarter Financial Results
09 Nov 2021 16:10:42 By Nasdaq GlobeNewswire